Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Assets (2021 - 2025)

Historic Return on Assets for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to 0.17%.

  • Krystal Biotech's Return on Assets rose 1100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.1% for FY2024, which is 800.0% up from last year.
  • Latest data reveals that Krystal Biotech reported Return on Assets of 0.17% as of Q3 2025, which was up 1100.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Return on Assets registered a high of 0.17% during Q3 2025, and its lowest value of 0.25% during Q1 2023.
  • For the 5-year period, Krystal Biotech's Return on Assets averaged around 0.04%, with its median value being 0.01% (2023).
  • In the last 5 years, Krystal Biotech's Return on Assets crashed by -1200bps in 2022 and then soared by 3500bps in 2024.
  • Krystal Biotech's Return on Assets (Quarter) stood at 0.13% in 2021, then crashed by -91bps to 0.25% in 2022, then skyrocketed by 106bps to 0.01% in 2023, then surged by 544bps to 0.09% in 2024, then soared by 91bps to 0.17% in 2025.
  • Its Return on Assets stands at 0.17% for Q3 2025, versus 0.13% for Q2 2025 and 0.12% for Q1 2025.